Key clinical point: Patients with interstitial lung disease who need anticoagulation therapy may have poorer long-term outcomes on warfarin than with oral anticoagulants.
Major finding: Compared with oral therapy, warfarin doubled the risk of lung transplant or death.
Study details: The retrospective cohort study comprised 1,918 patients.
Disclosures: Dr. King had no disclosures.
REPORTING FROM ATS 2019